Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemicals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116082296B reveals monopersulfate catalysis for benzothiophene. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112174880B reveals a mild, high-yield route to 1,3,4,6-tetra-substituted pyridones using cyclopropenones, offering cost-effective solutions for API manufacturing.
Patent CN108659046B reveals a robust route for tetramethyl spiroindane ligands. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis.
Patent CN108164483A details a novel arylation method for heterocycles using arylhydrazines, offering high yields and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN102154377B reveals ScCR enzyme for asymmetric reduction. Enables cost-effective manufacturing of pharmaceutical intermediates with self-regenerating cofactors.
Patent CN101880242B details a green Raney Nickel catalytic hydrogenation route for 3-amino-4-methoxyacetanilide, offering high purity and reduced environmental impact for dye manufacturers.
Novel diazotization route for 1-fluoro-2-bromo-3-iodobenzene ensures high yield and safety. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN110818733B reveals a high-efficiency disilylamine rare earth complex for hydroboration, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN105017110B reveals a cost-effective synthesis route for trifluoromethylthio reagents, offering significant supply chain stability and purity advantages for global pharmaceutical intermediates manufacturing.
Patent CN112961166A reveals a novel rare-earth catalyzed one-pot route for pyrano[2,3-b]indol-2-ones, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102154384A reveals efficient recombinant E. coli method yielding >26g/L with >99% ee, offering significant cost and supply chain advantages.
Patent CN110002980A reveals Pd-catalyzed asymmetric naphthylation for high-ee chiral aldehydes. Offers supply chain stability and cost reduction in chiral catalyst manufacturing.
Patent CN106220496B reveals a copper-catalyzed one-pot method for alpha-acyloxy ketones. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN114276375A details a catalyst-free synthesis of 1,3,2-benzodiazaborinones. Offers high purity, cost efficiency, and scalable green chemistry for API manufacturing.
Patent CN112852771A details enzymatic synthesis of chiral amino alcohols using imine reductase, offering high stereoselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN117903203A introduces a novel pyridine-based binuclear ligand enhancing enantioselectivity and offering cost reduction in asymmetric catalysis manufacturing for global supply chains.
Patent CN102924489A details a novel one-step synthesis of tri[(S)-leucinol]zinc bichloride. This report analyzes cost reduction and supply chain reliability for chiral catalyst manufacturing.
Novel CrCl3-catalyzed route for (S)-phenylglycinol hydrochloride. Enhances purity and reduces costs for pharmaceutical intermediate manufacturing.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.